nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0318	0.0454	CbGbCtD
Citalopram—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0299	0.0427	CbGbCtD
Citalopram—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0299	0.0427	CbGbCtD
Citalopram—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0271	0.0386	CbGbCtD
Citalopram—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0227	0.0324	CbGbCtD
Citalopram—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0208	0.0297	CbGbCtD
Citalopram—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0205	0.0293	CbGbCtD
Citalopram—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0202	0.0289	CbGbCtD
Citalopram—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.019	0.0271	CbGbCtD
Citalopram—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0187	0.0266	CbGbCtD
Citalopram—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0176	0.025	CbGbCtD
Citalopram—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0176	0.025	CbGbCtD
Citalopram—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0172	0.0245	CbGbCtD
Citalopram—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0172	0.0245	CbGbCtD
Citalopram—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0159	0.0226	CbGbCtD
Citalopram—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0154	0.0219	CbGbCtD
Citalopram—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0154	0.0219	CbGbCtD
Citalopram—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0149	0.0212	CbGbCtD
Citalopram—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0145	0.0206	CbGbCtD
Citalopram—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0145	0.0206	CbGbCtD
Citalopram—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0144	0.0206	CbGbCtD
Citalopram—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0139	0.0198	CbGbCtD
Citalopram—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0133	0.019	CbGbCtD
Citalopram—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0131	0.0187	CbGbCtD
Citalopram—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0131	0.0187	CbGbCtD
Citalopram—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.013	0.0186	CbGbCtD
Citalopram—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.013	0.0186	CbGbCtD
Citalopram—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0125	0.0178	CbGbCtD
Citalopram—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.012	0.0172	CbGbCtD
Citalopram—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.012	0.0171	CbGbCtD
Citalopram—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0116	0.0166	CbGbCtD
Citalopram—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0113	0.0161	CbGbCtD
Citalopram—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.011	0.0156	CbGbCtD
Citalopram—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0105	0.015	CbGbCtD
Citalopram—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0105	0.015	CbGbCtD
Citalopram—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0101	0.0144	CbGbCtD
Citalopram—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00991	0.0141	CbGbCtD
Citalopram—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00991	0.0141	CbGbCtD
Citalopram—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00978	0.014	CbGbCtD
Citalopram—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0092	0.0131	CbGbCtD
Citalopram—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0092	0.0131	CbGbCtD
Citalopram—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00832	0.0119	CbGbCtD
Citalopram—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00832	0.0119	CbGbCtD
Citalopram—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0078	0.0111	CbGbCtD
Citalopram—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00718	0.0102	CbGbCtD
Citalopram—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00697	0.00994	CbGbCtD
Citalopram—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0063	0.00899	CbGbCtD
Citalopram—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0063	0.00899	CbGbCtD
Citalopram—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00604	0.00862	CbGbCtD
Citalopram—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00213	0.056	CbGeAlD
Citalopram—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00171	0.0452	CbGeAlD
Citalopram—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00147	0.0388	CbGeAlD
Citalopram—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00122	0.0322	CbGeAlD
Citalopram—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000997	0.0263	CbGeAlD
Citalopram—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000956	0.0252	CbGeAlD
Citalopram—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000897	0.0236	CbGeAlD
Citalopram—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000722	0.019	CbGeAlD
Citalopram—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00071	0.0187	CbGeAlD
Citalopram—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.000567	0.015	CbGeAlD
Citalopram—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000566	0.0149	CbGeAlD
Citalopram—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000548	0.0145	CbGeAlD
Citalopram—SLC6A4—blood—acquired immunodeficiency syndrome	0.00054	0.0142	CbGeAlD
Citalopram—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.00052	0.0137	CbGeAlD
Citalopram—SLC6A3—lung—acquired immunodeficiency syndrome	0.000516	0.0136	CbGeAlD
Citalopram—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000511	0.0135	CbGeAlD
Citalopram—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000478	0.0126	CbGeAlD
Citalopram—SLC6A4—lung—acquired immunodeficiency syndrome	0.000473	0.0125	CbGeAlD
Citalopram—CHRM1—lung—acquired immunodeficiency syndrome	0.000471	0.0124	CbGeAlD
Citalopram—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000469	0.0124	CbGeAlD
Citalopram—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000469	0.0124	CbGeAlD
Citalopram—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000462	0.0122	CbGeAlD
Citalopram—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.00046	0.0121	CbGeAlD
Citalopram—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000459	0.0121	CbGeAlD
Citalopram—CYP2C19—blood—acquired immunodeficiency syndrome	0.000447	0.0118	CbGeAlD
Citalopram—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000445	0.0117	CbGeAlD
Citalopram—ADRA1A—blood—acquired immunodeficiency syndrome	0.000442	0.0116	CbGeAlD
Citalopram—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000438	0.0116	CbGeAlD
Citalopram—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000436	0.0115	CbGeAlD
Citalopram—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000422	0.0111	CbGeAlD
Citalopram—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.00042	0.0111	CbGeAlD
Citalopram—SLC6A2—lung—acquired immunodeficiency syndrome	0.000416	0.011	CbGeAlD
Citalopram—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000414	0.0109	CbGeAlD
Citalopram—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000386	0.0102	CbGeAlD
Citalopram—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000383	0.0101	CbGeAlD
Citalopram—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000372	0.00981	CbGeAlD
Citalopram—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000371	0.00979	CbGeAlD
Citalopram—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000367	0.00969	CbGeAlD
Citalopram—SLC6A3—brain—acquired immunodeficiency syndrome	0.000365	0.00963	CbGeAlD
Citalopram—CYP1A2—blood—acquired immunodeficiency syndrome	0.000365	0.00963	CbGeAlD
Citalopram—HRH1—digestive system—acquired immunodeficiency syndrome	0.000359	0.00946	CbGeAlD
Citalopram—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000359	0.00945	CbGeAlD
Citalopram—HTR2C—brain—acquired immunodeficiency syndrome	0.000353	0.00931	CbGeAlD
Citalopram—CYP2B6—blood—acquired immunodeficiency syndrome	0.00035	0.00923	CbGeAlD
Citalopram—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000349	0.00921	CbGeAlD
Citalopram—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000345	0.0091	CbGeAlD
Citalopram—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000345	0.00909	CbGeAlD
Citalopram—SLC6A4—brain—acquired immunodeficiency syndrome	0.000335	0.00883	CbGeAlD
Citalopram—CHRM1—brain—acquired immunodeficiency syndrome	0.000334	0.0088	CbGeAlD
Citalopram—CYP2E1—blood—acquired immunodeficiency syndrome	0.000329	0.00866	CbGeAlD
Citalopram—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000324	0.00856	CbGeAlD
Citalopram—CYP1A2—lung—acquired immunodeficiency syndrome	0.00032	0.00844	CbGeAlD
Citalopram—HRH1—vagina—acquired immunodeficiency syndrome	0.000317	0.00836	CbGeAlD
Citalopram—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000316	0.00835	CbGeAlD
Citalopram—CYP2B6—lung—acquired immunodeficiency syndrome	0.000307	0.00809	CbGeAlD
Citalopram—HRH1—lung—acquired immunodeficiency syndrome	0.0003	0.0079	CbGeAlD
Citalopram—SLC6A2—brain—acquired immunodeficiency syndrome	0.000295	0.00777	CbGeAlD
Citalopram—CYP2E1—lung—acquired immunodeficiency syndrome	0.000288	0.00759	CbGeAlD
Citalopram—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000285	0.00751	CbGeAlD
Citalopram—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000284	0.00749	CbGeAlD
Citalopram—ABCB1—retina—acquired immunodeficiency syndrome	0.00028	0.00738	CbGeAlD
Citalopram—HRH1—nervous system—acquired immunodeficiency syndrome	0.000278	0.00732	CbGeAlD
Citalopram—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000277	0.00732	CbGeAlD
Citalopram—ADRA1A—brain—acquired immunodeficiency syndrome	0.000274	0.00723	CbGeAlD
Citalopram—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000274	0.00721	CbGeAlD
Citalopram—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000273	0.0072	CbGeAlD
Citalopram—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000267	0.00705	CbGeAlD
Citalopram—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000267	0.00703	CbGeAlD
Citalopram—CYP3A4—blood—acquired immunodeficiency syndrome	0.000264	0.00697	CbGeAlD
Citalopram—CYP2D6—blood—acquired immunodeficiency syndrome	0.00026	0.00686	CbGeAlD
Citalopram—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000257	0.00677	CbGeAlD
Citalopram—CYP2B6—brain—acquired immunodeficiency syndrome	0.000217	0.00573	CbGeAlD
Citalopram—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000215	0.00566	CbGeAlD
Citalopram—HRH1—brain—acquired immunodeficiency syndrome	0.000212	0.00559	CbGeAlD
Citalopram—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000211	0.00557	CbGeAlD
Citalopram—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000207	0.00545	CbGeAlD
Citalopram—HRH1—lymph node—acquired immunodeficiency syndrome	0.000205	0.0054	CbGeAlD
Citalopram—CYP2E1—brain—acquired immunodeficiency syndrome	0.000204	0.00538	CbGeAlD
Citalopram—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000203	0.00536	CbGeAlD
Citalopram—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000199	0.00524	CbGeAlD
Citalopram—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000196	0.00518	CbGeAlD
Citalopram—ABCB1—blood—acquired immunodeficiency syndrome	0.000187	0.00493	CbGeAlD
Citalopram—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000181	0.00477	CbGeAlD
Citalopram—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.00018	0.00475	CbGeAlD
Citalopram—ABCB1—vagina—acquired immunodeficiency syndrome	0.000173	0.00457	CbGeAlD
Citalopram—ABCB1—lung—acquired immunodeficiency syndrome	0.000164	0.00433	CbGeAlD
Citalopram—CYP2D6—brain—acquired immunodeficiency syndrome	0.000161	0.00426	CbGeAlD
Citalopram—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000152	0.00401	CbGeAlD
Citalopram—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000146	0.00386	CbGeAlD
Citalopram—ABCB1—brain—acquired immunodeficiency syndrome	0.000116	0.00306	CbGeAlD
Citalopram—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000112	0.00296	CbGeAlD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	5.6e-05	0.000215	CcSEcCtD
Citalopram—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	5.58e-05	0.000214	CcSEcCtD
Citalopram—Pruritus—Abacavir—acquired immunodeficiency syndrome	5.57e-05	0.000214	CcSEcCtD
Citalopram—Fatigue—Indinavir—acquired immunodeficiency syndrome	5.57e-05	0.000214	CcSEcCtD
Citalopram—Anorexia—Delavirdine—acquired immunodeficiency syndrome	5.57e-05	0.000214	CcSEcCtD
Citalopram—Discomfort—Ritonavir—acquired immunodeficiency syndrome	5.57e-05	0.000214	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	5.57e-05	0.000213	CcSEcCtD
Citalopram—Cough—Saquinavir—acquired immunodeficiency syndrome	5.56e-05	0.000213	CcSEcCtD
Citalopram—Angioedema—Lamivudine—acquired immunodeficiency syndrome	5.56e-05	0.000213	CcSEcCtD
Citalopram—Pain—Indinavir—acquired immunodeficiency syndrome	5.53e-05	0.000212	CcSEcCtD
Citalopram—Constipation—Indinavir—acquired immunodeficiency syndrome	5.53e-05	0.000212	CcSEcCtD
Citalopram—Insomnia—Efavirenz—acquired immunodeficiency syndrome	5.52e-05	0.000212	CcSEcCtD
Citalopram—Urticaria—Zidovudine—acquired immunodeficiency syndrome	5.52e-05	0.000212	CcSEcCtD
Citalopram—Convulsion—Saquinavir—acquired immunodeficiency syndrome	5.52e-05	0.000212	CcSEcCtD
Citalopram—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	5.51e-05	0.000211	CcSEcCtD
Citalopram—Hypertension—Saquinavir—acquired immunodeficiency syndrome	5.5e-05	0.000211	CcSEcCtD
Citalopram—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	5.5e-05	0.000211	CcSEcCtD
Citalopram—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	5.5e-05	0.000211	CcSEcCtD
Citalopram—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	5.49e-05	0.00021	CcSEcCtD
Citalopram—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	5.49e-05	0.00021	CcSEcCtD
Citalopram—Malaise—Lamivudine—acquired immunodeficiency syndrome	5.48e-05	0.00021	CcSEcCtD
Citalopram—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	5.47e-05	0.00021	CcSEcCtD
Citalopram—Nausea—Didanosine—acquired immunodeficiency syndrome	5.47e-05	0.00021	CcSEcCtD
Citalopram—Vertigo—Lamivudine—acquired immunodeficiency syndrome	5.46e-05	0.000209	CcSEcCtD
Citalopram—Hypotension—Delavirdine—acquired immunodeficiency syndrome	5.46e-05	0.000209	CcSEcCtD
Citalopram—Syncope—Lamivudine—acquired immunodeficiency syndrome	5.45e-05	0.000209	CcSEcCtD
Citalopram—Confusional state—Ritonavir—acquired immunodeficiency syndrome	5.45e-05	0.000209	CcSEcCtD
Citalopram—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	5.45e-05	0.000209	CcSEcCtD
Citalopram—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	5.44e-05	0.000209	CcSEcCtD
Citalopram—Somnolence—Efavirenz—acquired immunodeficiency syndrome	5.43e-05	0.000208	CcSEcCtD
Citalopram—Chest pain—Saquinavir—acquired immunodeficiency syndrome	5.43e-05	0.000208	CcSEcCtD
Citalopram—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	5.43e-05	0.000208	CcSEcCtD
Citalopram—Myalgia—Saquinavir—acquired immunodeficiency syndrome	5.43e-05	0.000208	CcSEcCtD
Citalopram—Anxiety—Saquinavir—acquired immunodeficiency syndrome	5.41e-05	0.000207	CcSEcCtD
Citalopram—Oedema—Ritonavir—acquired immunodeficiency syndrome	5.4e-05	0.000207	CcSEcCtD
Citalopram—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	5.39e-05	0.000207	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	5.39e-05	0.000207	CcSEcCtD
Citalopram—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	5.38e-05	0.000206	CcSEcCtD
Citalopram—Discomfort—Saquinavir—acquired immunodeficiency syndrome	5.36e-05	0.000206	CcSEcCtD
Citalopram—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	5.34e-05	0.000205	CcSEcCtD
Citalopram—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	5.33e-05	0.000204	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	5.32e-05	0.000204	CcSEcCtD
Citalopram—Shock—Ritonavir—acquired immunodeficiency syndrome	5.32e-05	0.000204	CcSEcCtD
Citalopram—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	5.31e-05	0.000204	CcSEcCtD
Citalopram—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	5.31e-05	0.000203	CcSEcCtD
Citalopram—Cough—Lamivudine—acquired immunodeficiency syndrome	5.31e-05	0.000203	CcSEcCtD
Citalopram—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	5.31e-05	0.000203	CcSEcCtD
Citalopram—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	5.3e-05	0.000203	CcSEcCtD
Citalopram—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	5.29e-05	0.000203	CcSEcCtD
Citalopram—Dizziness—Stavudine—acquired immunodeficiency syndrome	5.29e-05	0.000203	CcSEcCtD
Citalopram—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	5.29e-05	0.000203	CcSEcCtD
Citalopram—Insomnia—Delavirdine—acquired immunodeficiency syndrome	5.29e-05	0.000203	CcSEcCtD
Citalopram—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	5.27e-05	0.000202	CcSEcCtD
Citalopram—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	5.27e-05	0.000202	CcSEcCtD
Citalopram—Convulsion—Lamivudine—acquired immunodeficiency syndrome	5.27e-05	0.000202	CcSEcCtD
Citalopram—Vomiting—Nevirapine—acquired immunodeficiency syndrome	5.27e-05	0.000202	CcSEcCtD
Citalopram—Fatigue—Efavirenz—acquired immunodeficiency syndrome	5.27e-05	0.000202	CcSEcCtD
Citalopram—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	5.25e-05	0.000201	CcSEcCtD
Citalopram—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	5.25e-05	0.000201	CcSEcCtD
Citalopram—Confusional state—Saquinavir—acquired immunodeficiency syndrome	5.25e-05	0.000201	CcSEcCtD
Citalopram—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	5.22e-05	0.0002	CcSEcCtD
Citalopram—Pain—Efavirenz—acquired immunodeficiency syndrome	5.22e-05	0.0002	CcSEcCtD
Citalopram—Constipation—Efavirenz—acquired immunodeficiency syndrome	5.22e-05	0.0002	CcSEcCtD
Citalopram—Rash—Nevirapine—acquired immunodeficiency syndrome	5.22e-05	0.0002	CcSEcCtD
Citalopram—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	5.22e-05	0.0002	CcSEcCtD
Citalopram—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	5.21e-05	0.0002	CcSEcCtD
Citalopram—Dizziness—Abacavir—acquired immunodeficiency syndrome	5.21e-05	0.0002	CcSEcCtD
Citalopram—Oedema—Saquinavir—acquired immunodeficiency syndrome	5.2e-05	0.000199	CcSEcCtD
Citalopram—Somnolence—Delavirdine—acquired immunodeficiency syndrome	5.2e-05	0.000199	CcSEcCtD
Citalopram—Headache—Nevirapine—acquired immunodeficiency syndrome	5.19e-05	0.000199	CcSEcCtD
Citalopram—Chest pain—Lamivudine—acquired immunodeficiency syndrome	5.18e-05	0.000198	CcSEcCtD
Citalopram—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	5.18e-05	0.000198	CcSEcCtD
Citalopram—Myalgia—Lamivudine—acquired immunodeficiency syndrome	5.18e-05	0.000198	CcSEcCtD
Citalopram—Infection—Saquinavir—acquired immunodeficiency syndrome	5.17e-05	0.000198	CcSEcCtD
Citalopram—Anxiety—Lamivudine—acquired immunodeficiency syndrome	5.16e-05	0.000198	CcSEcCtD
Citalopram—Anorexia—Ritonavir—acquired immunodeficiency syndrome	5.15e-05	0.000198	CcSEcCtD
Citalopram—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	5.14e-05	0.000197	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	5.14e-05	0.000197	CcSEcCtD
Citalopram—Urticaria—Indinavir—acquired immunodeficiency syndrome	5.14e-05	0.000197	CcSEcCtD
Citalopram—Shock—Saquinavir—acquired immunodeficiency syndrome	5.12e-05	0.000196	CcSEcCtD
Citalopram—Discomfort—Lamivudine—acquired immunodeficiency syndrome	5.11e-05	0.000196	CcSEcCtD
Citalopram—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	5.11e-05	0.000196	CcSEcCtD
Citalopram—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	5.11e-05	0.000196	CcSEcCtD
Citalopram—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	5.1e-05	0.000196	CcSEcCtD
Citalopram—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	5.1e-05	0.000196	CcSEcCtD
Citalopram—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	5.09e-05	0.000195	CcSEcCtD
Citalopram—Vomiting—Stavudine—acquired immunodeficiency syndrome	5.09e-05	0.000195	CcSEcCtD
Citalopram—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	5.08e-05	0.000195	CcSEcCtD
Citalopram—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	5.06e-05	0.000194	CcSEcCtD
Citalopram—Rash—Nelfinavir—acquired immunodeficiency syndrome	5.06e-05	0.000194	CcSEcCtD
Citalopram—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	5.05e-05	0.000194	CcSEcCtD
Citalopram—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	5.05e-05	0.000194	CcSEcCtD
Citalopram—Hypotension—Ritonavir—acquired immunodeficiency syndrome	5.05e-05	0.000194	CcSEcCtD
Citalopram—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	5.05e-05	0.000193	CcSEcCtD
Citalopram—Rash—Stavudine—acquired immunodeficiency syndrome	5.04e-05	0.000193	CcSEcCtD
Citalopram—Fatigue—Delavirdine—acquired immunodeficiency syndrome	5.04e-05	0.000193	CcSEcCtD
Citalopram—Dermatitis—Stavudine—acquired immunodeficiency syndrome	5.04e-05	0.000193	CcSEcCtD
Citalopram—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	5.03e-05	0.000193	CcSEcCtD
Citalopram—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	5.03e-05	0.000193	CcSEcCtD
Citalopram—Headache—Nelfinavir—acquired immunodeficiency syndrome	5.03e-05	0.000193	CcSEcCtD
Citalopram—Headache—Stavudine—acquired immunodeficiency syndrome	5.01e-05	0.000192	CcSEcCtD
Citalopram—Vomiting—Abacavir—acquired immunodeficiency syndrome	5.01e-05	0.000192	CcSEcCtD
Citalopram—Confusional state—Lamivudine—acquired immunodeficiency syndrome	5e-05	0.000192	CcSEcCtD
Citalopram—Pain—Delavirdine—acquired immunodeficiency syndrome	5e-05	0.000192	CcSEcCtD
Citalopram—Constipation—Delavirdine—acquired immunodeficiency syndrome	5e-05	0.000192	CcSEcCtD
Citalopram—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	5e-05	0.000192	CcSEcCtD
Citalopram—Asthenia—Zidovudine—acquired immunodeficiency syndrome	4.99e-05	0.000191	CcSEcCtD
Citalopram—Rash—Abacavir—acquired immunodeficiency syndrome	4.97e-05	0.00019	CcSEcCtD
Citalopram—Dermatitis—Abacavir—acquired immunodeficiency syndrome	4.96e-05	0.00019	CcSEcCtD
Citalopram—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	4.96e-05	0.00019	CcSEcCtD
Citalopram—Oedema—Lamivudine—acquired immunodeficiency syndrome	4.96e-05	0.00019	CcSEcCtD
Citalopram—Anorexia—Saquinavir—acquired immunodeficiency syndrome	4.96e-05	0.00019	CcSEcCtD
Citalopram—Headache—Abacavir—acquired immunodeficiency syndrome	4.94e-05	0.000189	CcSEcCtD
Citalopram—Infection—Lamivudine—acquired immunodeficiency syndrome	4.93e-05	0.000189	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	4.92e-05	0.000189	CcSEcCtD
Citalopram—Nausea—Nevirapine—acquired immunodeficiency syndrome	4.92e-05	0.000189	CcSEcCtD
Citalopram—Pruritus—Zidovudine—acquired immunodeficiency syndrome	4.92e-05	0.000189	CcSEcCtD
Citalopram—Insomnia—Ritonavir—acquired immunodeficiency syndrome	4.89e-05	0.000187	CcSEcCtD
Citalopram—Shock—Lamivudine—acquired immunodeficiency syndrome	4.88e-05	0.000187	CcSEcCtD
Citalopram—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	4.87e-05	0.000187	CcSEcCtD
Citalopram—Hypotension—Saquinavir—acquired immunodeficiency syndrome	4.86e-05	0.000186	CcSEcCtD
Citalopram—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	4.86e-05	0.000186	CcSEcCtD
Citalopram—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	4.85e-05	0.000186	CcSEcCtD
Citalopram—Urticaria—Efavirenz—acquired immunodeficiency syndrome	4.85e-05	0.000186	CcSEcCtD
Citalopram—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	4.83e-05	0.000185	CcSEcCtD
Citalopram—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	4.83e-05	0.000185	CcSEcCtD
Citalopram—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	4.82e-05	0.000185	CcSEcCtD
Citalopram—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	4.82e-05	0.000185	CcSEcCtD
Citalopram—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	4.82e-05	0.000185	CcSEcCtD
Citalopram—Somnolence—Ritonavir—acquired immunodeficiency syndrome	4.8e-05	0.000184	CcSEcCtD
Citalopram—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	4.8e-05	0.000184	CcSEcCtD
Citalopram—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	4.78e-05	0.000183	CcSEcCtD
Citalopram—Nausea—Nelfinavir—acquired immunodeficiency syndrome	4.77e-05	0.000183	CcSEcCtD
Citalopram—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	4.76e-05	0.000183	CcSEcCtD
Citalopram—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	4.76e-05	0.000182	CcSEcCtD
Citalopram—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	4.76e-05	0.000182	CcSEcCtD
Citalopram—Nausea—Stavudine—acquired immunodeficiency syndrome	4.75e-05	0.000182	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	4.74e-05	0.000182	CcSEcCtD
Citalopram—Anorexia—Lamivudine—acquired immunodeficiency syndrome	4.73e-05	0.000181	CcSEcCtD
Citalopram—Insomnia—Saquinavir—acquired immunodeficiency syndrome	4.71e-05	0.00018	CcSEcCtD
Citalopram—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	4.7e-05	0.00018	CcSEcCtD
Citalopram—Nausea—Abacavir—acquired immunodeficiency syndrome	4.68e-05	0.000179	CcSEcCtD
Citalopram—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	4.67e-05	0.000179	CcSEcCtD
Citalopram—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	4.67e-05	0.000179	CcSEcCtD
Citalopram—Fatigue—Ritonavir—acquired immunodeficiency syndrome	4.66e-05	0.000179	CcSEcCtD
Citalopram—Urticaria—Delavirdine—acquired immunodeficiency syndrome	4.64e-05	0.000178	CcSEcCtD
Citalopram—Asthenia—Indinavir—acquired immunodeficiency syndrome	4.64e-05	0.000178	CcSEcCtD
Citalopram—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	4.64e-05	0.000178	CcSEcCtD
Citalopram—Hypotension—Lamivudine—acquired immunodeficiency syndrome	4.64e-05	0.000178	CcSEcCtD
Citalopram—Somnolence—Saquinavir—acquired immunodeficiency syndrome	4.62e-05	0.000177	CcSEcCtD
Citalopram—Pain—Ritonavir—acquired immunodeficiency syndrome	4.62e-05	0.000177	CcSEcCtD
Citalopram—Constipation—Ritonavir—acquired immunodeficiency syndrome	4.62e-05	0.000177	CcSEcCtD
Citalopram—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	4.62e-05	0.000177	CcSEcCtD
Citalopram—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	4.62e-05	0.000177	CcSEcCtD
Citalopram—Dizziness—Zidovudine—acquired immunodeficiency syndrome	4.6e-05	0.000176	CcSEcCtD
Citalopram—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	4.58e-05	0.000176	CcSEcCtD
Citalopram—Pruritus—Indinavir—acquired immunodeficiency syndrome	4.57e-05	0.000175	CcSEcCtD
Citalopram—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	4.52e-05	0.000173	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	4.52e-05	0.000173	CcSEcCtD
Citalopram—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	4.5e-05	0.000173	CcSEcCtD
Citalopram—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	4.49e-05	0.000172	CcSEcCtD
Citalopram—Insomnia—Lamivudine—acquired immunodeficiency syndrome	4.49e-05	0.000172	CcSEcCtD
Citalopram—Fatigue—Saquinavir—acquired immunodeficiency syndrome	4.48e-05	0.000172	CcSEcCtD
Citalopram—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	4.46e-05	0.000171	CcSEcCtD
Citalopram—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	4.45e-05	0.000171	CcSEcCtD
Citalopram—Pain—Saquinavir—acquired immunodeficiency syndrome	4.45e-05	0.000171	CcSEcCtD
Citalopram—Constipation—Saquinavir—acquired immunodeficiency syndrome	4.45e-05	0.000171	CcSEcCtD
Citalopram—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	4.42e-05	0.00017	CcSEcCtD
Citalopram—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	4.42e-05	0.00017	CcSEcCtD
Citalopram—Vomiting—Zidovudine—acquired immunodeficiency syndrome	4.42e-05	0.000169	CcSEcCtD
Citalopram—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	4.42e-05	0.000169	CcSEcCtD
Citalopram—Somnolence—Lamivudine—acquired immunodeficiency syndrome	4.41e-05	0.000169	CcSEcCtD
Citalopram—Rash—Zidovudine—acquired immunodeficiency syndrome	4.38e-05	0.000168	CcSEcCtD
Citalopram—Asthenia—Efavirenz—acquired immunodeficiency syndrome	4.38e-05	0.000168	CcSEcCtD
Citalopram—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	4.38e-05	0.000168	CcSEcCtD
Citalopram—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	4.37e-05	0.000167	CcSEcCtD
Citalopram—Headache—Zidovudine—acquired immunodeficiency syndrome	4.36e-05	0.000167	CcSEcCtD
Citalopram—Pruritus—Efavirenz—acquired immunodeficiency syndrome	4.32e-05	0.000166	CcSEcCtD
Citalopram—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	4.31e-05	0.000165	CcSEcCtD
Citalopram—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	4.31e-05	0.000165	CcSEcCtD
Citalopram—Urticaria—Ritonavir—acquired immunodeficiency syndrome	4.29e-05	0.000165	CcSEcCtD
Citalopram—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	4.29e-05	0.000164	CcSEcCtD
Citalopram—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	4.28e-05	0.000164	CcSEcCtD
Citalopram—Fatigue—Lamivudine—acquired immunodeficiency syndrome	4.28e-05	0.000164	CcSEcCtD
Citalopram—Dizziness—Indinavir—acquired immunodeficiency syndrome	4.28e-05	0.000164	CcSEcCtD
Citalopram—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	4.27e-05	0.000164	CcSEcCtD
Citalopram—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	4.27e-05	0.000164	CcSEcCtD
Citalopram—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	4.25e-05	0.000163	CcSEcCtD
Citalopram—Pain—Lamivudine—acquired immunodeficiency syndrome	4.24e-05	0.000163	CcSEcCtD
Citalopram—Constipation—Lamivudine—acquired immunodeficiency syndrome	4.24e-05	0.000163	CcSEcCtD
Citalopram—Asthenia—Delavirdine—acquired immunodeficiency syndrome	4.19e-05	0.000161	CcSEcCtD
Citalopram—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	4.18e-05	0.00016	CcSEcCtD
Citalopram—Pruritus—Delavirdine—acquired immunodeficiency syndrome	4.14e-05	0.000159	CcSEcCtD
Citalopram—Urticaria—Saquinavir—acquired immunodeficiency syndrome	4.13e-05	0.000158	CcSEcCtD
Citalopram—Nausea—Zidovudine—acquired immunodeficiency syndrome	4.13e-05	0.000158	CcSEcCtD
Citalopram—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	4.11e-05	0.000158	CcSEcCtD
Citalopram—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	4.11e-05	0.000158	CcSEcCtD
Citalopram—Vomiting—Indinavir—acquired immunodeficiency syndrome	4.11e-05	0.000158	CcSEcCtD
Citalopram—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	4.09e-05	0.000157	CcSEcCtD
Citalopram—Rash—Indinavir—acquired immunodeficiency syndrome	4.08e-05	0.000156	CcSEcCtD
Citalopram—Dermatitis—Indinavir—acquired immunodeficiency syndrome	4.07e-05	0.000156	CcSEcCtD
Citalopram—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	4.06e-05	0.000156	CcSEcCtD
Citalopram—Headache—Indinavir—acquired immunodeficiency syndrome	4.05e-05	0.000155	CcSEcCtD
Citalopram—Dizziness—Efavirenz—acquired immunodeficiency syndrome	4.04e-05	0.000155	CcSEcCtD
Citalopram—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	4e-05	0.000153	CcSEcCtD
Citalopram—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	3.98e-05	0.000153	CcSEcCtD
Citalopram—Urticaria—Lamivudine—acquired immunodeficiency syndrome	3.94e-05	0.000151	CcSEcCtD
Citalopram—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	3.92e-05	0.00015	CcSEcCtD
Citalopram—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	3.92e-05	0.00015	CcSEcCtD
Citalopram—Vomiting—Efavirenz—acquired immunodeficiency syndrome	3.88e-05	0.000149	CcSEcCtD
Citalopram—Asthenia—Ritonavir—acquired immunodeficiency syndrome	3.88e-05	0.000149	CcSEcCtD
Citalopram—Dizziness—Delavirdine—acquired immunodeficiency syndrome	3.86e-05	0.000148	CcSEcCtD
Citalopram—Rash—Efavirenz—acquired immunodeficiency syndrome	3.85e-05	0.000148	CcSEcCtD
Citalopram—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	3.85e-05	0.000148	CcSEcCtD
Citalopram—Nausea—Indinavir—acquired immunodeficiency syndrome	3.84e-05	0.000147	CcSEcCtD
Citalopram—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	3.83e-05	0.000147	CcSEcCtD
Citalopram—Headache—Efavirenz—acquired immunodeficiency syndrome	3.83e-05	0.000147	CcSEcCtD
Citalopram—Pruritus—Ritonavir—acquired immunodeficiency syndrome	3.82e-05	0.000147	CcSEcCtD
Citalopram—Asthenia—Saquinavir—acquired immunodeficiency syndrome	3.73e-05	0.000143	CcSEcCtD
Citalopram—Vomiting—Delavirdine—acquired immunodeficiency syndrome	3.72e-05	0.000142	CcSEcCtD
Citalopram—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	3.7e-05	0.000142	CcSEcCtD
Citalopram—Rash—Delavirdine—acquired immunodeficiency syndrome	3.69e-05	0.000141	CcSEcCtD
Citalopram—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	3.68e-05	0.000141	CcSEcCtD
Citalopram—Pruritus—Saquinavir—acquired immunodeficiency syndrome	3.68e-05	0.000141	CcSEcCtD
Citalopram—Headache—Delavirdine—acquired immunodeficiency syndrome	3.66e-05	0.00014	CcSEcCtD
Citalopram—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	3.66e-05	0.00014	CcSEcCtD
Citalopram—Nausea—Efavirenz—acquired immunodeficiency syndrome	3.63e-05	0.000139	CcSEcCtD
Citalopram—Dizziness—Ritonavir—acquired immunodeficiency syndrome	3.57e-05	0.000137	CcSEcCtD
Citalopram—Asthenia—Lamivudine—acquired immunodeficiency syndrome	3.56e-05	0.000137	CcSEcCtD
Citalopram—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	3.56e-05	0.000136	CcSEcCtD
Citalopram—Pruritus—Lamivudine—acquired immunodeficiency syndrome	3.51e-05	0.000135	CcSEcCtD
Citalopram—Nausea—Delavirdine—acquired immunodeficiency syndrome	3.47e-05	0.000133	CcSEcCtD
Citalopram—Dizziness—Saquinavir—acquired immunodeficiency syndrome	3.44e-05	0.000132	CcSEcCtD
Citalopram—Vomiting—Ritonavir—acquired immunodeficiency syndrome	3.44e-05	0.000132	CcSEcCtD
Citalopram—Rash—Ritonavir—acquired immunodeficiency syndrome	3.41e-05	0.000131	CcSEcCtD
Citalopram—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	3.4e-05	0.000131	CcSEcCtD
Citalopram—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	3.4e-05	0.00013	CcSEcCtD
Citalopram—Headache—Ritonavir—acquired immunodeficiency syndrome	3.39e-05	0.00013	CcSEcCtD
Citalopram—Vomiting—Saquinavir—acquired immunodeficiency syndrome	3.31e-05	0.000127	CcSEcCtD
Citalopram—Dizziness—Lamivudine—acquired immunodeficiency syndrome	3.28e-05	0.000126	CcSEcCtD
Citalopram—Rash—Saquinavir—acquired immunodeficiency syndrome	3.28e-05	0.000126	CcSEcCtD
Citalopram—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	3.28e-05	0.000126	CcSEcCtD
Citalopram—Headache—Saquinavir—acquired immunodeficiency syndrome	3.26e-05	0.000125	CcSEcCtD
Citalopram—Nausea—Ritonavir—acquired immunodeficiency syndrome	3.21e-05	0.000123	CcSEcCtD
Citalopram—Vomiting—Lamivudine—acquired immunodeficiency syndrome	3.16e-05	0.000121	CcSEcCtD
Citalopram—Rash—Lamivudine—acquired immunodeficiency syndrome	3.13e-05	0.00012	CcSEcCtD
Citalopram—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	3.13e-05	0.00012	CcSEcCtD
Citalopram—Headache—Lamivudine—acquired immunodeficiency syndrome	3.11e-05	0.000119	CcSEcCtD
Citalopram—Nausea—Saquinavir—acquired immunodeficiency syndrome	3.09e-05	0.000118	CcSEcCtD
Citalopram—Nausea—Lamivudine—acquired immunodeficiency syndrome	2.95e-05	0.000113	CcSEcCtD
